Search

Your search keyword '"Mauriac L"' showing total 538 results

Search Constraints

Start Over You searched for: Author "Mauriac L" Remove constraint Author: "Mauriac L"
538 results on '"Mauriac L"'

Search Results

101. Carcinomes canalaires in situ bilatéraux: événements indépendants ou maladie bilatérale?

104. BIG 1–98: A randomized double-blind phase III study comparing letrozole and tamoxifen given in sequence vs. alone as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer

106. [Relay chemotherapy using continuous perfusion of cisplatin and fluoro-uracil in advanced cancer of the breast. Analysis of a series of 50 cases]

110. BIG 1–98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer

115. Summary version of the standards, options and recommendations for nonmetastatic breast cancer (updated January 2001)

116. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.

117. L’hormonothérapie néo-adjuvante en janvier 2005.

119. Analysis of 676 Cases of Ductal Carcinoma in Situ of the Breast From 1971 to 1995

120. ICI 182,780 (‘FASLODEX’) is at least as effective as anatrozole (Arimidex™) in post-menopausal women with advanced breast cancer progressing on prior endocrine treatment

124. Survival update of so14999 a large phase III trial of capecitabine/doxetaxel combination therapy vs docetaxel monotherapy in patients with locally advanced (LABC) or metastatic breast cancer (MBC)

127. Efficacy and safety of docetaxel (Taxotere™) in heavily pretreated advanced breast cancer patients

128. The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study. Results of an EORTC — NCIC — SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)

141. Endometrial carcinoma (EC) in women with breast cancer (BC)

146. A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *

Catalog

Books, media, physical & digital resources